Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
6-Nitroindazole is a synthetic small molecule belonging to the indazoles class, characterized by a nitro group at the sixth position of the indazole ring. It is primarily used as an experimental tool in pharmacological and biochemical research. Its main mechanism of action is as an inhibitor of neuronal nitric oxide synthase (nNOS), thereby modulating nitric oxide (NO) production in biological systems. This property has made it valuable for studying NO-mediated signaling pathways, neurodegenerative diseases, and potential therapeutic interventions for conditions such as chronic pain, inflammation, depression, and anxiety. Additionally, it exhibits anti-inflammatory and neuroprotective effects in preclinical models[1][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 6-nitroindazole.